相关实验视频
Updated: Jul 18, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
21.9K
八十岁和非六十岁的人中风的血栓溶解和血栓切除:一项区域观察研究
M Michelard1, O Detante2, O Heck3
1Medical intensive care unit, Grenoble Alpes University Hospital, Grenoble, France.
Revue neurologique
|August 18, 2023
概括
老年中风患者可以从IVT和MT等再输液疗法中受益. 这些治疗方法可以改善康复并降低死亡率,仅仅显示年龄不应该阻止它们在八十岁和非六十岁的人群中使用.
科学领域:
- 神经学 神经学
- 老年病的医生 老年病的医生
- 紧急医疗 紧急医疗
背景情况:
- 老年患者在中风病组中占有越来越多的人口,经常表现出更高的脆弱性.
- 对急性中风治疗的临床试验经常低于老年人群.
- 这项研究考察了重灌疗法在非常老年中风患者的现实有效性.
研究的目的:
- 在80岁及以上的患者中研究静脉静脉血栓溶解 (IVT) 和机械血栓切除 (MT) 的有效性.
- 为了比较接受急性中风治疗的八十岁 (80-89岁) 和非九十岁 (≥90岁) 患者之间的结果.
- 为了确定是否仅仅是年龄应该是对老年人再注射疗法的禁忌.
主要方法:
- 在2015-2020年期间连续住院的急性缺血性中风 (AIS) 患者的回顾性分析.
- 基线特征,早期神经恢复和年龄组之间的结果 (80-89岁与≥90岁) 的比较.
- 对接受IVT和/或MT的患者与没有接受IVT和/或MT的患者的评估.
主要成果:
- 重灌治疗 (IVT/MT) 给了787名80岁以上的患者 (632名80-89岁,155名≥90岁).
- 接受IVT/MT治疗的患者表现出显著更高的早期神经改善率 (45.6%对38.4%),改善结果 (OR=2.0) 和降低死亡率 (OR=0.5).
- 八代人有较好的功能结果 (36%vs25.7%mRS 0-2) 和较低的住院死亡率 (19.5%vs27.1%) 比非老年人,尽管类似的再通道化率.
结论:
- 静脉内血栓溶解和机械血栓切除显著提高早期的神经恢复和功能结果在八十岁和nonagenarians.
- 虽然与八十岁相比,nonagenarians体验的结果较差,但仅仅年龄不应该排除使用这些救命的再输液治疗.
- 目前的实践表明,在老年人中,再注射疗法具有好处,支持其继续应用.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Acute Coronary Syndrome III: Diagnostic Studies
10
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K

